Cogent Biosciences, Inc.
SEC Filing List
COGT CIK: 0001622229
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | E-Data Systems, Inc. /fa | 05/14/2026 | |||
| 8-K | Current report filing | Cogent Biosciences, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/05/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Cogent Biosciences, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/05/2026 | |
| DEF 14A | Definitive proxy statements | Cogent Biosciences, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/23/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Cogent Biosciences, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/23/2026 | |
| ARS | Annual report to security holders | Cogent Biosciences, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/23/2026 | |
| 4 | Statement of changes in beneficial owner... | Ferrante Karen Jean | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/03/2026 | |
| SCHEDULE 13D/A | Toppan Merrill/FA | 03/31/2026 | |||
| 144 | Filing for proposed sale of securities u... | Toppan Merrill/FA | 03/31/2026 | ||
| 4 | Statement of changes in beneficial owner... | Fairmount Funds Management Llc | Toppan Merrill/FA | 03/31/2026 | |
| No record found. | |||||
| Load More | |||||
